STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) |
1 Months Ended | 12 Months Ended | ||||
|---|---|---|---|---|---|---|
Jan. 15, 2025 |
Oct. 31, 2024
$ / shares
shares
|
Dec. 31, 2025
$ / shares
shares
|
Dec. 31, 2024
$ / shares
|
Oct. 24, 2024
$ / shares
|
Dec. 31, 2023
$ / shares
|
|
| Reverse split ratio | 0.02 | 0.02 | 0.02 | |||
| Warrant exercise price (in dollars per share) | $ / shares | $ 6.93 | $ 14.56 | $ 67.16 | |||
| Series A-3 warrant | ||||||
| Number of shares issuable upon exercise of warrants shares | shares | 337,552 | |||||
| Warrant exercise price (in dollars per share) | $ / shares | $ 11.85 | $ 11.85 | ||||
| Class of warrant or right, shares held in abeyance | shares | 255,552 | 185,880 | ||||
| X | ||||||||||
- Definition Number of shares held in abeyance and not considered outstanding pursuant to class of warrant or right. No definition available.
|
| X | ||||||||||
- Definition Number of shares issuable upon exercise of warrants. No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|